Welcome! This is the NEW free version of the SciBITES Pharma News Engine from SciBite. By using this site you to accept our Terms & Conditions which the use of cookies to enhance your user experience.


Here is the latest news for your query in chronological order, most recent articles at the top. Use the options on the right to filter and customise this news feed.

  Todays Pfizer (Tag) Articles ...

STABLE FORMULATIONS OF NEISSERIA MENINGITIDIS RLP2086 ANTIGENS
US/WO/EU Patents, , 22-Nov-2017
APIXABAN FORMULATIONS
US/WO/EU Patents, , 22-Nov-2017
Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC and a Moderate to High Risk
ClinicalTrials.gov, , 22-Nov-2017
Drug Use Investigation Of Selara(Registered) Tablets(an Investigation For Chronic Heart Failure)
ClinicalTrials.gov, , 22-Nov-2017
A Phase 1 Study Of The Safety, Pharmacokinetics And Anti-tumor Activity Of Talazoparib, Poly (Adp-ribose) Polymerase (Parp) Inhibitor, In Japanese Patients With Advanced Solid Tumors
ClinicalTrials.gov, , 22-Nov-2017
Randomized Phase II Trial of Pre-Operative Gemcitabine, Nab-Paclitaxel, and Hydroxychloroquine With or Without Avelumab (PGHA vs. PGH)
ClinicalTrials.gov, , 22-Nov-2017
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center Study To Evaluate The Efficacy And Safety Of Pf-04965842 Monotherapy In Subjects Aged 12 Years And Older, With Moderate To Severe Atopic Dermatitis
ClinicalTrials.gov, , 22-Nov-2017
Pfizer Inc. 2017 Q3 - Results - Earnings Call Slides
https://seekingalpha.com, , 21-Nov-2017
A Phase 1, Randomized, Multi-center, Double-blind, Sponsor Open, Placebo-controlled, Single And Multiple Dose-escalation Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis
ClinicalTrials.gov, , 21-Nov-2017
Pfizer Scores Sutent Win, But Bristol-Myers Looks To Steal Its Thunder
https://seekingalpha.com, , 20-Nov-2017
Sutent gets FDA approval for early use in kidney cancer
http://www.pmlive.com, , 20-Nov-2017
ESTIMATION OF CIRCULATING DRUG METABOLITE EXPOSURE IN HUMAN USING IN VITRO DATA AND PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELLING: EXAMPLE OF A HIGH METABOLITE/PARENT DRUG RATIO.
Medline, Drug metabolism and disposition: the biological fate of chemicals, 20-Nov-2017
GI-530159, a novel, selective, mechano-sensitive K2P channel opener, reduces rat dorsal root ganglion (DRG) neuron excitability.
Medline, British journal of pharmacology, 20-Nov-2017

  This Weeks Pfizer (Tag) Articles ...

Bond with Me If You Can! Natural Product, Covalent Ligand, and Reactivity-Based Probe Compete for Cysteine in PP2A Complex.
Medline, Cell chemical biology [24] 1317-1318, 19-Nov-2017
Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies.
Medline, The Journal of rheumatology, 18-Nov-2017
Pfizer receives FDA approval for SUTENT® (sunitinib malate) as first and only adjuvant treatment for adult patients at high risk of recurrent renal cell carcinoma
http://www.worldpharmanews.com, , 17-Nov-2017
Muscarinic receptor subtype distribution in the central nervous system and relevance to aging and Alzheimer's disease.
Medline, Neuropharmacology, 17-Nov-2017
Diabetes area patent participation analysis - Part II: Years 2011-2016.
Medline, Expert opinion on therapeutic patents, 17-Nov-2017
Efficacy of intravenous tigecycline in patients with Acinetobacter complex infections: results from 14 Phase III and Phase IV clinical trials.
Medline, Infection and drug resistance [10] 401-417, 17-Nov-2017
NEOS Is Poised To Take Advantage Of Missteps By Pfizer And Noven
https://seekingalpha.com, , 16-Nov-2017
Showing Records 0 ... 20  


SciBite
The Language Of Science

SciBite provides text-analytics and data intelligence software for drug discovery, clinical and competitor intelligence and much more for pharma, healthcare and life sciences.

This is a Limited, Free Service only touching the surface of how SciBite's tools transform biomedical text, literature, patents, internal documents and news into a rich intelligence network. If you'd like to know more, contact us to see how our tools can transform your work today!

Topic Activity & Tools

Get Daily Alerts!

Click For Email & RSS Alerts

About/Links

Name: Pfizer (Tag)
Type: Company

Filters

Source:


Must Mention A:


In Context:


Insights

Show Most Frequent


Optional, Only Include Source:


Tools

[Not available (Why?)]